Sambhv Steel Tubes Fund Raise of ₹440 Cr

Sambhv Steel Tubes Business Update

Sambhv Steel Tubes executed a five-year services agreement with Sachin Tendulkar for endorsement and marketing of its steel products under the 'Sambhv' brand. The agreement takes effect from December 07, 2026, and no monetary value is disclosed.

Execution

5 years from December 07, 2026

Sambhv Steel Tubes Earnings Call Transcript: Key Takeaways

Management focused on volume growth in structural pipes despite margin compression from Chinese dumping and monsoon impacts.

Sambhv Steel Tubes Investor Presentation: Key Takeaways

Q2FY27 standalone revenue Rs836 Cr (+44% YoY), PAT Rs61 Cr (+104%), Op. EBITDA Rs101 Cr (+68%). Vision 2030 targets over 2 MMTPA finished capacity.

Sambhv Steel Tubes Q2 FY27 Results: Net Profit ₹60.9 Cr, Up 99.0% YoY

Sambhv Steel Tubes Ltd reported revenue from operations of ₹836 Cr (+44.1% YoY) and net profit of ₹60.9 Cr (+99.0% YoY) for Q2 FY27.

Key figure

Net profit ₹60.9 Cr · +99.0% YoY

Sambhv Steel Tubes Board Meeting Date

Sambhv Steel Tubes will hold a board meeting on 29 October 2026 to consider unaudited quarterly results for September 2026. The trading window stays closed until 31 October 2026.

Sambhv Steel Tubes Other Announcement

Sambhv Steel Tubes Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. This is a routine regulatory compliance disclosure.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.